{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:33:52Z","timestamp":1778128432428,"version":"3.51.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/npp.2017.85","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T11:00:23Z","timestamp":1493204423000},"page":"2259-2271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls"],"prefix":"10.1038","volume":"42","author":[{"given":"Rachel A","family":"Rabin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mera S","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarissa","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantine K","family":"Zakzanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Kish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony P","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"BFnpp201785_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"22","author":"D Addington","year":"1993","unstructured":"Addington D, Addington J, Maticka-Tyndale E (1993). Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 22: 39\u201344.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFnpp201785_CR2","unstructured":"APA Diagnostic and Statistical Manual Of Mental Disorders. 4th edn. American Psychiatric Association: Washington, DC, USA, 1994."},{"key":"BFnpp201785_CR3","unstructured":"APA Diagnostic and Statistical Manual Of Mental Disorders (Revised 4th ed.). American Psychiatric Association: Washington, DC, USA, 2000."},{"key":"BFnpp201785_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1017\/S0033291700030324","volume":"22","author":"S Arndt","year":"1992","unstructured":"Arndt S, Tyrrell G, Flaum M, Andreasen NC (1992). Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 22: 379\u2013388.","journal-title":"Psychol Med"},{"key":"BFnpp201785_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TR Barnes","year":"1989","unstructured":"Barnes TR (1989). A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672\u2013676.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201785_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","volume":"50","author":"A Bechara","year":"1994","unstructured":"Bechara A, Damasio AR, Damasio H, Anderson SW (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50: 7\u201315.","journal-title":"Cognition"},{"key":"BFnpp201785_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","volume":"59","author":"KI Bolla","year":"2002","unstructured":"Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL (2002). Dose-related neurocognitive effects of marijuana use. Neurology 59: 1337\u20131343.","journal-title":"Neurology"},{"key":"BFnpp201785_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.pneurobio.2010.06.010","volume":"92","author":"MG Bossong","year":"2010","unstructured":"Bossong MG, Niesink RJ (2010). Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92: 370\u2013385.","journal-title":"Prog Neurobiol"},{"key":"BFnpp201785_CR9","unstructured":"Brandt J, Benedict R (2001) Hopkins Verbal Learning Test-Revised. In: Professional Manual. PAR, Inc.: Lutz, FL."},{"key":"BFnpp201785_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","volume":"79","author":"SJ Broyd","year":"2016","unstructured":"Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N (2016). Acute and chronic effects of cannabinoids on human cognition-A systematic review. Biol Psychiatry 79: 557\u2013567.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201785_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/0021-843X.112.3.393","volume":"112","author":"AJ Budney","year":"2003","unstructured":"Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003). The time course and significance of cannabis withdrawal. J Abnorm Psychol 112: 393\u2013402.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp201785_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H et al (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117\u20131127.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201785_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/adb.12116","volume":"20","author":"J Ceccarini","year":"2015","unstructured":"Ceccarini J, Kuepper R, Kemels D, van Os J, Henquet C, Van Laere K (2015). [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol 20: 357\u2013367.","journal-title":"Addict Biol"},{"key":"BFnpp201785_CR14","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Inc.: Hillsdale, New Jersey, 1988.."},{"key":"BFnpp201785_CR15","volume-title":"Conners\u2019 Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual","author":"CK Conners","year":"2000","unstructured":"Conners CK (2000) Conners\u2019 Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual. Multi-Health Systems: North Tonawanda, NY, USA."},{"key":"BFnpp201785_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","volume":"136","author":"ZD Cooper","year":"2014","unstructured":"Cooper ZD, Haney M (2014). Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend 136: 85\u201391.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201785_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.schres.2007.08.006","volume":"96","author":"CM Coulston","year":"2007","unstructured":"Coulston CM, Perdices M, Tennant CC (2007a). The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse\/dependence, frequency of use, and recency of use. Schizophr Res 96: 169\u2013184.","journal-title":"Schizophr Res"},{"key":"BFnpp201785_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/00048670701634952","volume":"41","author":"CM Coulston","year":"2007","unstructured":"Coulston CM, Perdices M, Tennant CC (2007b). The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry 41: 869\u2013884.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFnpp201785_CR19","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.pain.2013.05.017","volume":"154","author":"RM Craft","year":"2013","unstructured":"Craft RM, Kandasamy R, Davis SM (2013). Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Delta(9)-tetrahydrocannabinol in the rat. Pain 154: 1709\u20131717.","journal-title":"Pain"},{"key":"BFnpp201785_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","volume":"57","author":"DC D'Souza","year":"2005","unstructured":"D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G et al (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57: 594\u2013608.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201785_CR21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","volume":"148","author":"L Dixon","year":"1991","unstructured":"Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148: 224\u2013230.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201785_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/clpt.1985.226","volume":"38","author":"GM Ellis Jr","year":"1985","unstructured":"Ellis GM Jr, Mann MA, Judson BA, Schramm NT, Tashchian A (1985). Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 38: 572\u2013578.","journal-title":"Clin Pharmacol Ther"},{"key":"BFnpp201785_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1360-0443.2005.01322.x","volume":"101","author":"DM Fergusson","year":"2006","unstructured":"Fergusson DM, Boden JM, Horwood LJ (2006). Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101: 556\u2013569.","journal-title":"Addiction"},{"key":"BFnpp201785_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jat\/32.8.562","volume":"32","author":"RS Goodwin","year":"2008","unstructured":"Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA (2008). Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol 32: 562\u2013569.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201785_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","volume":"26","author":"MF Green","year":"2000","unstructured":"Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \"right stuff\"? Schizophr Bull 26: 119\u2013136.","journal-title":"Schizophr Bull"},{"key":"BFnpp201785_CR26","first-page":"20","volume":"12","author":"W Guy","year":"1976","unstructured":"Guy W, Cleary PA (1976). Pretreatment status and its relationship to the length of drying-out period. Psychopharmacol Bull 12: 20\u201322.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp201785_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278\u2013296.","journal-title":"Br J Soc Clin Psychol"},{"key":"BFnpp201785_CR28","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","volume":"72","author":"DS Hasin","year":"2015","unstructured":"Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H et al (2015). Prevalence of Marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry 72: 1235\u20131242.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp201785_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119\u20131127.","journal-title":"Br J Addict"},{"key":"BFnpp201785_CR30","volume-title":"Wisconsin Card Sorting Test Manual","author":"RK Heaton","year":"1993","unstructured":"Heaton RK, Chelune GJ, Talley JL (1993) Wisconsin Card Sorting Test Manual. Psychological Assessment Resources: Odessa, FL, USA."},{"key":"BFnpp201785_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","volume":"12","author":"RW Heinrichs","year":"1998","unstructured":"Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12: 426\u2013445.","journal-title":"Neuropsychology"},{"key":"BFnpp201785_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1192\/bjp.bp.109.072249","volume":"196","author":"C Henquet","year":"2010","unstructured":"Henquet C, van Os J, Kuepper R, Delespaul P, Smits M, Campo JA et al (2010). Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry 196: 447\u2013453.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201785_CR33","first-page":"129","volume":"112","author":"M Herkenham","year":"1991","unstructured":"Herkenham M (1991). Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr 112: 129\u2013145.","journal-title":"NIDA Res Monogr"},{"key":"BFnpp201785_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1037\/0894-4105.12.1.52","volume":"12","author":"T Hershey","year":"1998","unstructured":"Hershey T, Craft S, Glauser TA, Hale S (1998). Short-term and long-term memory in early temporal lobe dysfunction. Neuropsychology 12: 52\u201364.","journal-title":"Neuropsychology"},{"key":"BFnpp201785_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","volume":"17","author":"J Hirvonen","year":"2012","unstructured":"Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C et al (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17: 642\u2013649.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201785_CR36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.pnpbp.2007.03.006","volume":"31","author":"MC Jockers-Scherubl","year":"2007","unstructured":"Jockers-Scherubl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gomez-Carrillo de Castro A et al (2007). Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 31: 1054\u20131063.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp201785_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261\u2013276.","journal-title":"Schizophr Bull"},{"key":"BFnpp201785_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","volume":"142","author":"EJ Khantzian","year":"1985","unstructured":"Khantzian EJ (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142: 1259\u20131264.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201785_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1037\/0096-3445.128.1.78","volume":"128","author":"KN Kirby","year":"1999","unstructured":"Kirby KN, Petry NM, Bickel WK (1999). Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 128: 78\u201387.","journal-title":"J Exp Psychol Gen"},{"key":"BFnpp201785_CR40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","volume":"36","author":"J Koskinen","year":"2010","unstructured":"Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36: 1115.","journal-title":"Schizophr Bull"},{"key":"BFnpp201785_CR41","first-page":"623","volume":"13","author":"LH Lacritz","year":"1998","unstructured":"Lacritz LH, Cullum CM (1998). The Hopkins Verbal Learning Test and CVLT: a preliminary comparison. Arch Clin Neuropsychol 13: 623\u2013628.","journal-title":"Arch Clin Neuropsychol"},{"key":"BFnpp201785_CR42","unstructured":"Lafayette Instrument Company (1989) Instruction Manual for the 32025 Grooved Pegboard Test. Lafayette Instrument Company: Lafayette, Indiana."},{"key":"BFnpp201785_CR43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","volume":"68","author":"M Large","year":"2011","unstructured":"Large M, Sharma S, Compton MT, Slade T, Nielssen O (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 68: 555\u2013561.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201785_CR44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/schbul\/sbq153","volume":"38","author":"VC Leeson","year":"2011","unstructured":"Leeson VC, Harrison I, Ron MA, Barnes TR, Joyce EM (2011). The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull 38: 873\u2013880.","journal-title":"Schizophr Bull"},{"key":"BFnpp201785_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1037\/1076-898X.8.2.75","volume":"8","author":"CW Lejuez","year":"2002","unstructured":"Lejuez CW, Read JP, Kahler CW, Richards JB, Ramsey SE, Stuart GL et al (2002). Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 8: 75\u201384.","journal-title":"J Exp Psychol Appl"},{"key":"BFnpp201785_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.eurpsy.2011.04.010","volume":"27","author":"S Lev-Ran","year":"2012","unstructured":"Lev-Ran S, Segev A, Braw Y, Levkovitz Y (2012). Neurocognitive functions of heavy cannabis using schizophrenia patients. Eur Psychiatry 27: 365\u2013368.","journal-title":"Eur Psychiatry"},{"key":"BFnpp201785_CR47","volume-title":"Neuropsychological Assessment","author":"MD Lezak","year":"2004","unstructured":"Lezak MD, Howieson DB, Loring DW Neuropsychological Assessment. 4th edn. Oxford University Press: New York, 2004."},{"key":"BFnpp201785_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","volume":"168","author":"K Mackie","year":"2005","unstructured":"Mackie K (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168: 299\u2013325.","journal-title":"Handb Exp Pharmacol"},{"key":"BFnpp201785_CR49","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1017\/S0033291714000191","volume":"44","author":"E Manrique-Garcia","year":"2014","unstructured":"Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P (2014). Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med 44: 2513\u20132521.","journal-title":"Psychol Med"},{"key":"BFnpp201785_CR50","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1017\/S1355617707071032","volume":"13","author":"KL Medina","year":"2007","unstructured":"Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF (2007). Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc 13: 807\u2013820.","journal-title":"J Int Neuropsychol Soc"},{"key":"BFnpp201785_CR51","doi-asserted-by":"publisher","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","volume":"109","author":"MH Meier","year":"2012","unstructured":"Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS et al (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 109: E2657\u2013E2664.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201785_CR52","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319\u2013328.","journal-title":"Lancet"},{"key":"BFnpp201785_CR53","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1586\/14737175.8.7.1037","volume":"8","author":"KR Muller-Vahl","year":"2008","unstructured":"Muller-Vahl KR, Emrich HM (2008). Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Exp Rev Neurother 8: 1037\u20131048.","journal-title":"Exp Rev Neurother"},{"key":"BFnpp201785_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hup.332","volume":"16","author":"G Nahas","year":"2001","unstructured":"Nahas G (2001). The Pharmacokinetics of the THC in fat and brain: resulting functional responses to marihuana smoking: G. Nahas, Volume 16 Issue 3, April 2001, pages 247-255. Hum Psychopharmacol 16: 549.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp201785_CR55","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00213-015-4160-2","volume":"233","author":"C Nunez","year":"2016","unstructured":"Nunez C, Ochoa S, Huerta-Ramos E, Banos I, Barajas A, Dolz M et al (2016). Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology 233: 809\u2013821.","journal-title":"Psychopharmacology"},{"key":"BFnpp201785_CR56","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","volume":"6","author":"R Patel","year":"2016","unstructured":"Patel R, Wilson R, Jackson R, Ball M, Shetty H, Broadbent M et al (2016). Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open 6: e009888.","journal-title":"BMJ Open"},{"key":"BFnpp201785_CR57","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","volume":"58","author":"HG Pope Jr","year":"2001","unstructured":"Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001). Neuropsychological performance in long-term cannabisusers. Arch Gen Psychiatry 58: 909\u2013915.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201785_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bandc.2005.04.002","volume":"59","author":"S Potvin","year":"2005","unstructured":"Potvin S, Briand C, Prouteau A, Bouchard RH, Lipp O, Lalonde P et al (2005). CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn 59: 38\u201342.","journal-title":"Brain Cogn"},{"key":"BFnpp201785_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.schres.2011.02.017","volume":"128","author":"R Rabin","year":"2011","unstructured":"Rabin R, Zakzanis K, George T (2011). The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res 128: 111\u2013116.","journal-title":"Schizophr Res"},{"key":"BFnpp201785_CR60","unstructured":"Rabin RA, Kozak K, Zakzanis KK, Remington G, George TP (2017). A method to achieve 28 days of cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophr Res (e-pub ahead of print)."},{"key":"BFnpp201785_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.psychres.2012.11.019","volume":"206","author":"RA Rabin","year":"2013","unstructured":"Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP (2013). Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Res 206: 158\u2013165.","journal-title":"Psychiatry Res"},{"key":"BFnpp201785_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","volume":"188","author":"M Ranganathan","year":"2006","unstructured":"Ranganathan M, D\u2019Souza DC (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188: 425\u2013444.","journal-title":"Psychopharmacology"},{"key":"BFnpp201785_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1037\/1040-3590.10.1.10","volume":"10","author":"LM Rees","year":"1998","unstructured":"Rees LM, Tombaugh TN, Gansler DA, Moczynski NP (1998). Five validation experiments of the test of memory malingering(TOMM). Psychol Assess 10: 10\u201320.","journal-title":"Psychol Assess"},{"key":"BFnpp201785_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.schres.2012.10.021","volume":"143","author":"PA Ringen","year":"2013","unstructured":"Ringen PA, Melle I, Berg AO, Agartz I, Spigset O, Simonsen C et al (2013). Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder. Schizophr Res 143: 84\u201389.","journal-title":"Schizophr Res"},{"key":"BFnpp201785_CR65","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1017\/S0033291709991620","volume":"40","author":"PA Ringen","year":"2010","unstructured":"Ringen PA, Vaskinn A, Sundet K, Engh JA, Jonsdottir H, Simonsen C et al (2010). Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med 40: 1337\u20131347.","journal-title":"Psychol Med"},{"key":"BFnpp201785_CR66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.schres.2010.08.017","volume":"124","author":"JM Rodriguez-Sanchez","year":"2010","unstructured":"Rodriguez-Sanchez JM, Ayesa-Arriola R, Mata I, Moreno-Calle T, Perez-Iglesias R, Gonzalez-Blanch C et al (2010). Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr Res 124: 142\u2013151.","journal-title":"Schizophr Res"},{"key":"BFnpp201785_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.schres.2006.03.025","volume":"85","author":"KA Sacco","year":"2006","unstructured":"Sacco KA, Termine A, Dudas MM, Seyal AA, Allen TM, Vessicchio JC et al (2006). Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophr Res 85: 213\u2013221.","journal-title":"Schizophr Res"},{"key":"BFnpp201785_CR68","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2014II. Addiction 88: 791\u2013804.","journal-title":"Addiction"},{"key":"BFnpp201785_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00213-009-1512-9","volume":"205","author":"T Schnell","year":"2009","unstructured":"Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology 205: 45\u201352.","journal-title":"Psychopharmacology"},{"key":"BFnpp201785_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1360-0443.2010.03228.x","volume":"106","author":"EW Schwilke","year":"2011","unstructured":"Schwilke EW, Gullberg RG, Darwin WD, Chiang CN, Cadet JL, Gorelick DA et al (2011). Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction 106: 499\u2013506.","journal-title":"Addiction"},{"key":"BFnpp201785_CR71","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.acn.2006.12.004","volume":"22","author":"MJ Sharland","year":"2007","unstructured":"Sharland MJ, Gfeller JD (2007). A survey of neuropsychologists' beliefs and practices with respect to the assessment of effort. Arch Clin Neuropsychol 22: 213\u2013223.","journal-title":"Arch Clin Neuropsychol"},{"key":"BFnpp201785_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11\u201319.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"BFnpp201785_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jat\/23.5.323","volume":"23","author":"A Smith-Kielland","year":"1999","unstructured":"Smith-Kielland A, Skuterud B, Morland J (1999). Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 23: 323\u2013332.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201785_CR74","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","volume":"83","author":"LC Sobell","year":"1988","unstructured":"Sobell LC, Sobell MB, Leo GI, Cancilla A (1988). Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83: 393\u2013402.","journal-title":"Br J Addict"},{"key":"BFnpp201785_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1874473710801010081","volume":"1","author":"N Solowij","year":"2008","unstructured":"Solowij N, Battisti R (2008). The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1: 81\u201398.","journal-title":"Curr Drug Abuse Rev"},{"key":"BFnpp201785_CR76","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij N, Stephens R, Roffman RA, Babor T (2002). Does marijuana use cause long-term cognitive deficits? J Am Med Assoc 287: 2653\u20132654 author reply 2654.","journal-title":"J Am Med Assoc"},{"key":"BFnpp201785_CR77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","volume":"99","author":"LR Squire","year":"1992","unstructured":"Squire LR (1992). Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99: 195\u2013231.","journal-title":"Psychol Rev"},{"key":"BFnpp201785_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.bp.106.029009","volume":"192","author":"A Szoke","year":"2008","unstructured":"Szoke A, Trandafir A, Dupont ME, Meary A, Schurhoff F, Leboyer M (2008). Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 192: 248\u2013257.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201785_CR79","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/j.1360-0443.2011.03574.x","volume":"106","author":"RJ Tait","year":"2011","unstructured":"Tait RJ, Mackinnon A, Christensen H (2011). Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction 106: 2195\u20132203.","journal-title":"Addiction"},{"key":"BFnpp201785_CR80","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1037\/1040-3590.9.3.260","volume":"9","author":"TN Tombaugh","year":"1997","unstructured":"Tombaugh TN (1997). The Test of Memory Malingering (TOMM): normative data from cognitively intact and cognitively impaired individuals. Psychol Assess 9: 260\u2013268.","journal-title":"Psychol Assess"},{"key":"BFnpp201785_CR81","volume-title":"Wechsler Test of Adult Reading","author":"D Wechsler","year":"2001","unstructured":"Wechsler D (2001) Wechsler Test of Adult Reading. Psychological Corporation: San Antonio."},{"key":"BFnpp201785_CR82","volume-title":"Wechsler Adult Intelligence Scale","author":"DA Wechsler","year":"1997","unstructured":"Wechsler DA (1997) Wechsler Adult Intelligence Scale. 3rd (edn). The Psychological Corporation.: San Antonio, TX, USA."},{"key":"BFnpp201785_CR83","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/schbul\/sbq079","volume":"38","author":"M Yucel","year":"2012","unstructured":"Yucel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM et al (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull 38: 316\u2013330.","journal-title":"Schizophr Bull"},{"key":"BFnpp201785_CR84","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1192\/bjp.bp.107.046375","volume":"193","author":"S Zammit","year":"2008","unstructured":"Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 193: 357\u2013363.","journal-title":"Br J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201785","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp201785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:46:40Z","timestamp":1692780400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFnpp201785"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.85","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"assertion":[{"value":"18 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}